{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T22:36:02Z","timestamp":1773182162038,"version":"3.50.1"},"reference-count":28,"publisher":"BMJ","issue":"9","funder":[{"name":"Romanian Society of Cardiology","award":["266\/8.06.2021"],"award-info":[{"award-number":["266\/8.06.2021"]}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["CH\/09\/002"],"award-info":[{"award-number":["CH\/09\/002"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["FS\/ICRF\/20\/26002"],"award-info":[{"award-number":["FS\/ICRF\/20\/26002"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["FS\/SCRF\/21\/32010"],"award-info":[{"award-number":["FS\/SCRF\/21\/32010"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["RE\/18\/5\/34216"],"award-info":[{"award-number":["RE\/18\/5\/34216"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["RG\/F\/22\/110093"],"award-info":[{"award-number":["RG\/F\/22\/110093"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sir Jules Thorn Award for Biomedical Research","award":["15\/JTA"],"award-info":[{"award-number":["15\/JTA"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2023,10,10]]},"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Aortic stenosis (AS) shares pathophysiological similarities with atherosclerosis including active inflammation. CT attenuation of perivascular adipose tissue provides a measure of vascular inflammation that is linked to prognosis and has the potential to be applied to the aortic valve. We investigated perivascular adipose tissue attenuation around the aortic valve in patients with AS.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>CT attenuation was measured in the perivascular adipose tissue extending 3\u2009mm radially and 10\u2009mm longitudinally around the aortic valve in patients with and without AS. Associations between perivascular adipose tissue attenuation and AS disease severity, activity and progression were investigated.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Perivascular adipose tissue attenuation around the aortic valve demonstrated good intraobserver and interobserver repeatability (interobserver: intraclass correlation coefficient 0.977 (95% CI: 0.94, 0.99)) but was similar between patients with AS (n=120) and control subjects (n=80) (\u221262.4 (\u221268.7, \u221256.5) Hounsfield units (HU) vs \u221261.2 (\u221265.3, \u221255.6) HU, p=0.099). There were no differences between perivascular adipose tissue attenuation in patients with mild (\u221260.2 (\u221266.9, \u221255.1) HU), moderate (\u221262.8 (\u221269.6, \u221256.80) HU) or severe (\u221262.3 (\u221269.3, \u221255.4) HU) AS (all p&gt;0.05), and perivascular adipose tissue attenuation did not demonstrate an association with AS severity as assessed by echocardiography or CT calcium scoring, nor with disease activity assessed by <jats:sup>18<\/jats:sup>F-sodium fluoride positron emission tomography. Moreover, there was no association between baseline aortic valve perivascular adipose tissue attenuation and subsequent AS progression (annualised change in peak velocity: r=0.072, p=0.458). Similar results were found using five other image analysis methods.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>CT-derived aortic valve perivascular adipose tissue attenuation is not associated with AS disease severity, activity or progression suggesting that it has no value in the investigation and management of patients with AS.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/heartjnl-2023-323217","type":"journal-article","created":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T13:22:00Z","timestamp":1698931320000},"page":"657-665","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Aortic valve perivascular adipose tissue computed tomography attenuation in patients with aortic stenosis"],"prefix":"10.1136","volume":"110","clinical-trial-number":[{"clinical-trial-number":"nct02132026","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02110303","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-9605-0426","authenticated-orcid":false,"given":"Simona B","family":"Botezatu","sequence":"first","affiliation":[{"name":"British Heart Foundation Centre for Cardiovascular Science, The University of Edinburgh, Edinburgh, UK"},{"name":"Cardiology Department, Euroecolab, University of Medicine and Pharmacy 'Carol Davila', Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinming","family":"Yu","sequence":"additional","affiliation":[{"name":"British Heart Foundation Centre for Cardiovascular Science, The University of Edinburgh, Edinburgh, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0806-9972","authenticated-orcid":false,"given":"Mohammed N","family":"Meah","sequence":"additional","affiliation":[{"name":"British Heart Foundation Centre for Cardiovascular Science, The University of Edinburgh, Edinburgh, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3556-2428","authenticated-orcid":false,"given":"Michelle C","family":"Williams","sequence":"additional","affiliation":[{"name":"British Heart Foundation Centre for Cardiovascular Science, The University of Edinburgh, Edinburgh, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2236-6970","authenticated-orcid":false,"given":"Damini","family":"Dey","sequence":"additional","affiliation":[{"name":"Biomedical Imaging Research Institute, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7971-4628","authenticated-orcid":false,"given":"David E","family":"Newby","sequence":"additional","affiliation":[{"name":"British Heart Foundation Centre for Cardiovascular Science, The University of Edinburgh, Edinburgh, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0038-043X","authenticated-orcid":false,"given":"Evangelos","family":"Tzolos","sequence":"additional","affiliation":[{"name":"British Heart Foundation Centre for Cardiovascular Science, The University of Edinburgh, Edinburgh, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc R","family":"Dweck","sequence":"additional","affiliation":[{"name":"British Heart Foundation Centre for Cardiovascular Science, The University of Edinburgh, Edinburgh, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,11,2]]},"reference":[{"key":"2025100706402381000_110.9.657.1","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/ejcts\/ezac209","article-title":"2021 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"62","author":"Beyersdorf","year":"2022","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025100706402381000_110.9.657.2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.crad.2020.04.007","article-title":"Imaging aortic valve calcification: significance, approach and implications","volume":"76","author":"Fletcher","year":"2021","journal-title":"Clin Radiol"},{"key":"2025100706402381000_110.9.657.3","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.113.001508"},{"key":"2025100706402381000_110.9.657.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.06.1325"},{"key":"2025100706402381000_110.9.657.5","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2022-321158"},{"key":"2025100706402381000_110.9.657.6","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal2658","article-title":"Detecting human coronary inflammation by imaging perivascular fat","volume":"9","author":"Antonopoulos","year":"2017","journal-title":"Sci Transl Med"},{"key":"2025100706402381000_110.9.657.7","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jcct.2021.03.005","article-title":"Pericoronary adipose tissue CT attenuation and its association with serum levels of atherosclerosis-relevant inflammatory mediators, coronary calcification and major adverse cardiac events","volume":"15","author":"Goeller","year":"2021","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"2025100706402381000_110.9.657.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31114-0"},{"key":"2025100706402381000_110.9.657.9","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s10554-019-01758-8","article-title":"Perivascular fat attenuation index and high-risk plaque features evaluated by coronary CT angiography: relationship with serum inflammatory marker level","volume":"36","author":"Dai","year":"2020","journal-title":"Int J Cardiovasc Imaging"},{"key":"2025100706402381000_110.9.657.10","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.016202","article-title":"Determinants of Pericoronary Adipose tissue Attenuation on computed tomography angiography in coronary artery disease","volume":"9","author":"Sugiyama","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"2025100706402381000_110.9.657.11","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1161\/CIRCULATIONAHA.121.053708","article-title":"Effect of denosumab or alendronic acid on the progression of aortic stenosis: a double-blind randomized controlled trial","volume":"143","author":"Pawade","year":"2021","journal-title":"Circulation"},{"key":"2025100706402381000_110.9.657.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2019.05.023"},{"key":"2025100706402381000_110.9.657.13","unstructured":"Health Research Authority . UK policy framework for health and social care research. n.d. Available: https:\/\/www.hra.nhs.uk\/planning-and-improving-research\/policies-standards-legislation\/uk-policy-framework-health-social-care-research\/"},{"key":"2025100706402381000_110.9.657.14","unstructured":"WMA - . Ethical principles for medical research involving human subjects. n.d. Available: https:\/\/www.wma.net\/policies-post\/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects\/"},{"key":"2025100706402381000_110.9.657.15","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/ehjci\/jew335","article-title":"Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography","volume":"18","author":"Baumgartner","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2025100706402381000_110.9.657.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2019.01.045"},{"key":"2025100706402381000_110.9.657.17","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(90)90282-T"},{"key":"2025100706402381000_110.9.657.18","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.005131","article-title":"Optimization and reproducibility of aortic valve 18F-fluoride positron emission tomography in patients with aortic stenosis","volume":"9","author":"Pawade","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"2025100706402381000_110.9.657.19","doi-asserted-by":"publisher","DOI":"10.1007\/s12350-018-01542-6"},{"key":"2025100706402381000_110.9.657.20","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.10100681"},{"key":"2025100706402381000_110.9.657.21","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/ehjci\/jez013","article-title":"Relationship between changes in pericoronary adipose tissue attenuation and coronary plaque burden quantified from coronary computed tomography angiography","volume":"20","author":"Goeller","year":"2019","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2025100706402381000_110.9.657.22","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1007\/s10554-022-02716-7","article-title":"Vessel and sex differences in pericoronary adipose tissue attenuation obtained with coronary CT in individuals without coronary atherosclerosis","volume":"38","author":"van Rosendael","year":"2022","journal-title":"Int J Cardiovasc Imaging"},{"key":"2025100706402381000_110.9.657.23","doi-asserted-by":"crossref","first-page":"iv7","DOI":"10.1136\/heartjnl-2012-302395","article-title":"Degenerative calcific aortic stenosis: a natural history","volume":"98 Suppl 4","author":"Iung","year":"2012","journal-title":"Heart"},{"key":"2025100706402381000_110.9.657.24","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.119.313067"},{"key":"2025100706402381000_110.9.657.25","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.90.2.844"},{"key":"2025100706402381000_110.9.657.26","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-012-9579-6"},{"key":"2025100706402381000_110.9.657.27","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2014-000152","article-title":"High sensitivity C reactive protein as a prognostic marker in patients with mild to moderate aortic valve stenosis during lipid-lowering treatment: an SEAS substudy","volume":"2","author":"Blyme","year":"2015","journal-title":"Open Heart"},{"key":"2025100706402381000_110.9.657.28","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht034"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2023-323217","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T13:57:15Z","timestamp":1759845435000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2023-323217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,2]]},"references-count":28,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,4,15]]},"published-print":{"date-parts":[[2024,5]]}},"alternative-id":["10.1136\/heartjnl-2023-323217"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2023-323217","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,2]]}}}